RESUMEN
Titanocene dichloride is one of the most promising cancerostatica of the future: nevertheless, its high activity against several tumor cells was discovered 20 years ago. Detailed knowledge of the mechanism of hydrolysis of titanocene dichloride and its stability in the infusion liquid is a prerequisite for clinical tests and for a successful application for permission as medication. Capillary electrophoresis (CE) was used to observe the hydrolysis behavior of titanocene dichloride in aqueous solutions. The hydrolysis products were separated in a 20 mM phosphate buffer, pH 6, and in a 20 mM malic acid buffer, pH 3. Up to five hydrolysis products were obtained. A significant influence of the sample preparation (pH, isoionic additives) on the hydrolysis rate was observed. The hydrolysis products were characterized by the UV scan and the element-selective particle-induced X-ray emission (PIXE) detection technique. The results obtained correspond with the hydrolysis mechanism described in the literature. The determination of free titanocene dichloride in human plasma failed due to the high affinity of the plasma proteins for this compound.
Asunto(s)
Antineoplásicos/análisis , Compuestos Organometálicos/análisis , Antineoplásicos/farmacocinética , Electroforesis Capilar , Compuestos Organometálicos/farmacocinética , SolucionesRESUMEN
Modern research into the physiology of the blood circulation has been influenced decisively by Carl Ludwig. His contributions to the special field of microcirculation are typical examples of his scientific mode of thinking, being characterised by exactness and richness of ideas. His demand for a useful division of the complete circulatory system into two parts, namely the intra- and extravascular circulation, has remarkable heuristic value. His ideas concerning the functions of the extravascular space have maintained their validity up to the present day. His conception of the existence of open connections between the interstitial compartments and the inside of the lymphatic vessels was far ahead of contemporary knowledge: the relevant findings and ideas of Ludwig look, in part, like "confirmations" or anticipations of modern investigation results. This is illustrated by corresponding examples. As far as his scientific conceptions are concerned Ludwig was very particular to abstain from admission of any hypothetic throughts into them. The high reliability of his conceptions resulting from this custom is exemplified by comparing his interpretation of fluid and substance exchange in the terminal vessel area with "Starling's law" as the currently accepted explanation of these processes.
Asunto(s)
Circulación Sanguínea/fisiología , Modelos Cardiovasculares , Alemania , Historia del Siglo XIX , Humanos , Microcirculación , Fisiología/historiaRESUMEN
The s.c. injection of cis-DDP into ABD2F1 mice (8 mg/kg b.m.) resulted in alterations of size and surface structure of peritoneal macrophages (PM) and in a reduction of the mean number of Concanavalin A (ConA) binding sites of PM. The PM population of control mice which received physiological saline only consisted of 2 subgroups with a higher and a lower mean ConA binding site number per cell. Contrarily, PM of cis-DDP-treated mice failed the subpopulation with higher ConA binding site number. A loss of this subpopulation was also found in mice treated with platinum salt K2PtCl4 or K2PtCl6. X-ray microanalytically determined elemental contents of PM of control and treated mice showed a correlation between ConA binding site number and cellular concentration of phosphorus or sulphur with the exception of a small group of PM which was characterized by a high content of sulphur and a low number of ConA binding site. This correlation was not found in normal mice.
Asunto(s)
Cisplatino/farmacología , Macrófagos/citología , Cavidad Peritoneal/citología , Platino (Metal)/farmacología , Animales , Sitios de Unión , Cisplatino/administración & dosificación , Concanavalina A/metabolismo , Microanálisis por Sonda Electrónica , Inyecciones Subcutáneas , Macrófagos/metabolismo , Macrófagos/ultraestructura , Masculino , Ratones , Microscopía Electrónica de Rastreo , Microscopía Fluorescente , Fotometría , Platino (Metal)/administración & dosificaciónRESUMEN
Using a new technique to mimic arteriolar occlusion syndromes, different microparticles were injected into the ophthalmic artery of pigs. These microparticles were platelet aggregates of various sizes ranging from 0.15 mm to more than 0.8 mm. Aggregation was induced using adenosine diphosphate and thrombin. In some experiments, acetylsalicylic acid and histamine were also applied. In a further series of experiments, mixed aggregates containing platelets and leukocytes were injected. The results were observed by indirect ophthalmoscopy and consisted of superficial and deep retinal infarction. Large platelet aggregates resulted in arterial branch occlusion, whereas mixed and small platelet aggregates produced occlusion of small arterioles. This technique seems to be valuable in studying retinal arteriolar occlusion syndromes.
Asunto(s)
Modelos Animales de Enfermedad , Agregación Plaquetaria , Oclusión de la Arteria Retiniana/etiología , Adenosina Difosfato , Animales , Femenino , Fondo de Ojo , Leucocitos , Arteria Oftálmica/patología , Arteria Retiniana/patología , Oclusión de la Arteria Retiniana/patología , Porcinos , TrombinaRESUMEN
Laboratory and clinical observations have implicated microparticles in the pathogenesis of Purtscher's retinopathy, which leads to the occlusion of small arterioles. These microparticles may be caused by aggregated leukocyte platelets or fibrin clots. The phenomenon of intravascular coagulation is well known following trauma or acute pancreatitis. Purtscher's retinopathy is linked with both diseases. To support this presumed pathogenesis of Purtscher's retinopathy, fibrin clots ranging in size from 0.15 to 1.0 mm were injected into the ophthalmic artery of the pig. They resulted in superficial and deep retinal infarctions. In addition, flame-shaped and spotted hemorrhages occurred. These retinal changes are characteristic of Purtscher's retinopathy.
Asunto(s)
Enfermedades de la Retina/etiología , Animales , Coagulación Sanguínea , Modelos Animales de Enfermedad , Femenino , Fibrina , Fondo de Ojo , Arteria Oftálmica , Oclusión de la Arteria Retiniana/complicaciones , Hemorragia Retiniana/etiología , PorcinosAsunto(s)
Islotes Pancreáticos/efectos de los fármacos , Compuestos Organoplatinos/toxicidad , Animales , Antineoplásicos/toxicidad , Cisplatino/análogos & derivados , Cisplatino/toxicidad , Prueba de Tolerancia a la Glucosa , Islotes Pancreáticos/patología , Masculino , Enfermedades Pancreáticas/inducido químicamente , Enfermedades Pancreáticas/patología , Ratas , Ratas EndogámicasRESUMEN
Using K562 tumour cells as model, the effect of cisplatin on cellular morphology and electrolyte balance was examined by scanning electron microscopy and energy-dispersive X-ray microanalysis. The data imply that the membrane surface alterations are a secondary effect following cross-linking reaction of this drug with DNA.
Asunto(s)
División Celular/efectos de los fármacos , Membrana Celular/ultraestructura , Cisplatino/farmacología , Línea Celular , Membrana Celular/efectos de los fármacos , Membrana Celular/fisiología , Microanálisis por Sonda Electrónica , Humanos , Leucemia Mielógena Crónica BCR-ABL Positiva , Microscopía Electrónica de RastreoRESUMEN
Five diammine-Pt(II) or Pt(IV) coordination compounds, namely cis-diammine-dichloro-platinum (II) "cis-DDP", transdihydroxy-cis-diammine-dichloro-platinum (IV) "trans-ODDP", and derived substitution products of lactic acid (racemates or L-forms) with diminished toxicity in comparison to cis-DDP have been tested against mouse leukemia P388, and partly on melanoma B16 for antineoplastic activity. The results have been compared with those obtained with the clinical approved cis-DDP. They were not in every way equal to the antitumor efficiency of cis-DDP. Improved physicochemical properties as well as favorable differences of side effects in contrast to cis-DDP, could be decisive for the potential value of these substances.
Asunto(s)
Antineoplásicos/uso terapéutico , Cisplatino/uso terapéutico , Leucemia P388/tratamiento farmacológico , Melanoma Experimental/tratamiento farmacológico , Compuestos Organoplatinos/uso terapéutico , Animales , Antineoplásicos/administración & dosificación , Cisplatino/administración & dosificación , Cisplatino/análogos & derivados , Esquema de Medicación , Femenino , Inyecciones Intraperitoneales , Leucemia Experimental , Masculino , Ratones , Ratones Endogámicos , Compuestos Organoplatinos/administración & dosificación , Relación Estructura-ActividadRESUMEN
In comparison with cis-DDP four new platinum (II) and platinum (IV) complexes were evaluated for their acute nephrotoxic and myelotoxic potency in male rats following i.v. administration of maximum tolerated doses on 5 consecutive days. Parameters for nephrotoxicity determined on day 6, 13 and 22 after the first administration of the drugs included blood, urea nitrogen, serum creatinine, urine volume, urinary glucose and tubule cell excretion. Parameters for myelotoxicity determined on the same days included leucocytes, platelets, hemoglobin and hematocrit. Cis-DDP was found to be the most nephrotoxic compound. The myelotoxicity of the new platinum complexes appeared to be similar to that of cis-DDP with exception of trans-ODDP.
Asunto(s)
Antineoplásicos/toxicidad , Médula Ósea/efectos de los fármacos , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Cisplatino/toxicidad , Riñón/efectos de los fármacos , Compuestos Organoplatinos/toxicidad , Animales , Antineoplásicos/administración & dosificación , Cisplatino/administración & dosificación , Cisplatino/análogos & derivados , Inyecciones Intravenosas , Masculino , Compuestos Organoplatinos/administración & dosificación , Ratas , Ratas EndogámicasRESUMEN
After single i.v. administration of cis-diammine-platinum(II)-lactate cis-diammine-platinum(II)-lactate, L cis-diammine-platinum(II)-dilactate trans-dihydroxy-cis-dichlorodiammine-platinum(IV), the LD50 values have been calculated to range between 80 and 130 mg/kg in mice, and between 22 and 45 mg/kg in rats. The LD50 of cis-DDP amounted to 17 mg/kg and 6.6 mg/kg, respectively. Likewise, the compounds have been found to be about 3 to 5 times less toxic than the standard cis-DDP when administered daily for 5 consecutive days. Since the kidneys, the bone marrow, the lymphatic tissue and the intestinal tract have been proved to be the main target organs, the profile of the toxic action of the Pt(II)-complexes seems to be similar to that of cis-DDP. Additionally, the Pt(IV) compound has been found to be toxic to the pancreas, the liver and the salivary glands. With regard to the antineoplastic activity the more soluble lactates of cis-DDP showed a smaller therapeutic index compared to cis-DDP.
Asunto(s)
Antineoplásicos/toxicidad , Cisplatino/toxicidad , Compuestos Organoplatinos/toxicidad , Animales , Antineoplásicos/administración & dosificación , Cisplatino/administración & dosificación , Cisplatino/análogos & derivados , Inyecciones Intravenosas , Dosificación Letal Mediana , Masculino , Ratones , Compuestos Organoplatinos/administración & dosificación , Ratas , Ratas EndogámicasRESUMEN
4-Methyl-2-amino-pyridine-palladium chloride (MAP) showed an antiviral activity against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in a serum-free medium under in vitro conditions. The replication of these viruses on primary rabbit testes cells was completely suppressed by 10(-5) M/l MAP. In animal tests using ABD2-mice the course of HSV-1 and HSV-2 encephalitis was not influenced by MAP indicated by mean survival time and lethality.
Asunto(s)
Antivirales/farmacología , Herpes Simple/tratamiento farmacológico , Compuestos Organometálicos/farmacología , Picolinas/farmacología , Simplexvirus/efectos de los fármacos , Animales , Antivirales/uso terapéutico , Células Cultivadas , Femenino , Ratones , Compuestos Organometálicos/uso terapéutico , Picolinas/uso terapéutico , Organismos Libres de Patógenos EspecíficosRESUMEN
The effect on retroviruses of two transition metal complexes of known antiviral activity, 4-methyl-2-amino-pyridine-palladium-chloride (MAP) and cis-dichloro-diammine-platinum(II) (cis-DDP) has been investigated. The experiments included the evaluation of the action of compounds on virus particle-associated reverse transcriptase in exogenous assays, on virus propagation in persistently infected cell cultures and on virus infectivity in mice. In disrupted viruses and in the absence of excess protein, the reverse transcriptase was inhibited by MAP but not by cis-DDP. The same results were obtained when examining the activity of the virus-associated RNA polymerase of influenza virus A/WSN. Both compounds did not inhibit the replication of retroviruses in cell cultures, except at high dose levels which exerted toxic action on both cells and virus formation. The leukemogenicity of Rauscher murine leukemia virus was strongly inhibited when the virus had been incubated with MAP before inoculation. A similar treatment with cis-DDP did not influence viral leukemogenicity. Despite somewhat different results with both compounds tested, we conclude from the present results that the above mentioned compounds cannot be considered as antiretroviral drugs.
Asunto(s)
Antivirales/farmacología , Cisplatino/farmacología , Virus de la Influenza A/efectos de los fármacos , Compuestos Organometálicos , Paladio/farmacología , Picolinas/farmacología , Retroviridae/efectos de los fármacos , Animales , Línea Celular , ARN Polimerasas Dirigidas por ADN/antagonistas & inhibidores , Humanos , Virus de la Influenza A/enzimología , Retroviridae/enzimología , Retroviridae/crecimiento & desarrollo , Inhibidores de la Transcriptasa Inversa , Replicación Viral/efectos de los fármacosRESUMEN
In water or dimethyl sulfoxide solutions cis-platinum is subject of time depending solvolytic reactions leading to compounds with different biological effectivity. Whereas the inactivation of vaccinia, vesicular stomatitis and adeno virus type 5 was not changed if dimethyl sulfoxide or dimethyl formamide instead of destilled water were used as solvents, long time stored solutions of cis-platinum in dimethyl sulfoxide were tolerated by cells cultivated in vitro in 8-25 times higher concentrations in comparison with a freshly solved preparation. Their antiviral effectivity was maintained. On the other hand experiments with mice showed that simultaneously with the decrease of toxicity of an aged cis-platinum solution in DMSO also its antileukemic activity disappeared. In a 5 weeks old cis-platinum solution in destilled water antitumor activity was preserved in spite of enhanced toxicity.
Asunto(s)
Cisplatino/farmacología , Dimetilsulfóxido/farmacología , Adenovirus Humanos/efectos de los fármacos , Animales , Células Cultivadas , Embrión de Pollo , Cisplatino/uso terapéutico , Dimetilsulfóxido/administración & dosificación , Interacciones Farmacológicas , Tolerancia a Medicamentos , Femenino , Células L/efectos de los fármacos , Leucemia Experimental/tratamiento farmacológico , Masculino , Ratones , Ratones Endogámicos , Soluciones , Virus Vaccinia/efectos de los fármacos , Virus de la Estomatitis Vesicular Indiana/efectos de los fármacosRESUMEN
The beta-lactamase-inhibiting activity of 6m-ethyl-pyrid-2-yl-ammine palladium-dichloride (Pd 25681) and cis-dichloro-diammine-platinum(II) was studied and compared with the enzyme inhibitory action of potassium clavulanate and the penicillanic acid sulfone CP 45899. Using the nitrocefin test method and the Titertek/Microtiter equipment CP 45899 and potassium clavulanate were the strongest inhibitors of the Bacillus cereus beta-lactamase. Cis-dichloro-diammine-platinum(II) was fourfold less active than the palladium complex PD 25681 in äquimolar concentration. The following ID50 values were found: CP 45899: 0.0281 microgram; K-clavulanate: 0.1274 microgram; Pd 25681: 3.8603 microgram; cis-dichlorodiammine-platinum(II): 12.5120 microgram/100 microliter.
Asunto(s)
Antineoplásicos/farmacología , Cisplatino/farmacología , Ácidos Clavulánicos/farmacología , Compuestos Organometálicos , Paladio/farmacología , Ácido Penicilánico/farmacología , Picolinas/farmacología , Inhibidores de beta-Lactamasas , Bacillus cereus/efectos de los fármacos , Ácido Clavulánico , Relación Dosis-Respuesta a Droga , SulbactamAsunto(s)
Hemodinámica , Microcirculación/fisiología , Animales , Permeabilidad Capilar , Humanos , Ratas , Venas/fisiologíaRESUMEN
The coordination compound cis-dichlorodiammineplatinum(II) (cis-DDP) was shown by Rosenberg et al. (17) to exhibit antitumour activity. Several authors have indicated limited virustatic properties of cis-DDP against bacterial, oncogenic, avipox and paramyxo viruses. In our investigations, cis-DDP significantly showed an antiviral action in vitro against enveloped DNA and RNA viruses, such as vaccinia, pseudorabies, herpes simplex type 1, Newcastle disease, influenza A/fowl plague, influenza A/Victoria 3/75, influenza A/Jena 48/78, influenza B/Johannesburg and vesicular stomatitis viruses. Out of the group of nonenveloped viruses, adenovirus type 4 and 5 were inhibited, whereas no inhibition against naked cardiovirus Mengo could be estimated. The antiviral action was proved against extracellular virus by dialysis experiments with vaccinia virus and also during the replication cycles of enveloped viruses. In trials with cell-free viruses the plaque reduction of all sensitive viruses mentioned above amounted to 100 per cent in comparison to the untreated controls caused by virus inactivation with loss of infectivity in contact with several concentrations of cis-DDP. On the other hand, the addition of the compound for one hour only immediately after infection or up to 8 hrs later produced a complete depression of further multiplication of vaccinia virus. Likewise, the replication of influenza virus A/FPV or VSV was inhibited whereas the multiplication of adenoviruses was not influenced in a comparable manner.
Asunto(s)
Antivirales/farmacología , Cisplatino/farmacología , Virus/efectos de los fármacos , Adenoviridae/efectos de los fármacos , Herpesvirus Suido 1/efectos de los fármacos , Mengovirus/efectos de los fármacos , Virus de la Enfermedad de Newcastle/efectos de los fármacos , Orthomyxoviridae/efectos de los fármacos , Virus Vaccinia/efectos de los fármacos , Virus de la Estomatitis Vesicular Indiana/efectos de los fármacos , Ensayo de Placa Viral , Replicación Viral/efectos de los fármacosRESUMEN
In view of the fact that bis cyclopentadienyl metal dihalides are known to be anti-tumour drugs, we have investigated the antiviral activity of this type of coordination compounds. Bis cyclopentadienyl titanium dichloride (a) has shown significant antiviral efficiency in vitro against representatives of a nuber of enveloped DNA and RNA viruses. Inhibition of orthopoxvirus (vaccinia), herpes virus (pseudorabies), orthomyxoviruses (influenza A/fowl plague [FPV], influenza A/Victoria 3/75, influenza A/jena 48/78 and influenza B/Johannesburg), paramyxovirus (Newcastle disease [NDV]) and rhabdovirus (vesicular stomatitis [VSV]) was observed after direct contact with the compound under loss of infectivity up to 100%. Regarding the group of unenveloped viruses only adenovirus type 4 became influenced but not type 5. No antiviral activity could be found against the cardiovirus Mengo. The compound bis cyclopentadienyl molybdenum dichloride failed to show an antiviral action versus vaccinia, influenza A/FPV and influenza viruses B/Johannesburg. Application of the inhibitor (a) during the replication of vaccinia and influenza viruses A/FPV in cell cultures produced an additional effect of inhibition of virus multiplication. On the other hand, adenovirus type 4 and VSV replication was not affected by titanocene dichloride.